TY - JOUR
T1 - Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells
AU - Jones, Nancy H.
AU - Borowitz, Michael J.
AU - Metzgar, Richard S.
N1 - Funding Information:
*This work was supported by grant CA 08975 from the National Cancer Institute and grant AM 08054 from the National Institutes of Arthritis, Metabolism and Digestive Diseases.
PY - 1982
Y1 - 1982
N2 - A monoclonal antibody (DU-ALL-1) was generated to common acute lymphoblastic leukemia (cALL) cells by microcytotoxicity and indirect immunofluorescence, DU-ALL-1 reacted only with cALL cell lines and not with the other hematopoietic cell lines tested. Peripheral blood lymphocytes, monocytes, granulocytes and mitogen-activated lymphocytes did not react significantly with this antibody. However, platelets (100%) and normal bone marrow cells (8.5%) reacted with DU-ALL-1. Microcytotoxicity testing of human leukemia cells showed that DU-ALL-1 reacted with cells from a majority of null and pre-B ALL patients ( 63 77) and with cells from some patients with acute myeloblastic leukemia ( 4 7) and T-ALL ( 4 20). DU-ALL-1 was generally non-reactive with cells from patients with B-cell leukemias ( 2 16) and chronic myelogenous leukemia in blast crisis ( 0 4). By an indirect immunoperoxidase technique. DU-ALL-1 reacted with a variety of non-hematopoietic tissues, including smooth and cardiac muscle and epithelia from several organs. The DU-ALL-1 antigen had an apparent mol. wt of 24,000 and did not bind to lectins or label with [3H]glucosamine. Thus, DU-ALL-1 defines a 24,000-mol. wt protein which is absent from most peripheral blood mononuclear cells, is expressed on normal platelets and several non-hematopoietic tissues, and may be a useful for subclassifying leukemias.
AB - A monoclonal antibody (DU-ALL-1) was generated to common acute lymphoblastic leukemia (cALL) cells by microcytotoxicity and indirect immunofluorescence, DU-ALL-1 reacted only with cALL cell lines and not with the other hematopoietic cell lines tested. Peripheral blood lymphocytes, monocytes, granulocytes and mitogen-activated lymphocytes did not react significantly with this antibody. However, platelets (100%) and normal bone marrow cells (8.5%) reacted with DU-ALL-1. Microcytotoxicity testing of human leukemia cells showed that DU-ALL-1 reacted with cells from a majority of null and pre-B ALL patients ( 63 77) and with cells from some patients with acute myeloblastic leukemia ( 4 7) and T-ALL ( 4 20). DU-ALL-1 was generally non-reactive with cells from patients with B-cell leukemias ( 2 16) and chronic myelogenous leukemia in blast crisis ( 0 4). By an indirect immunoperoxidase technique. DU-ALL-1 reacted with a variety of non-hematopoietic tissues, including smooth and cardiac muscle and epithelia from several organs. The DU-ALL-1 antigen had an apparent mol. wt of 24,000 and did not bind to lectins or label with [3H]glucosamine. Thus, DU-ALL-1 defines a 24,000-mol. wt protein which is absent from most peripheral blood mononuclear cells, is expressed on normal platelets and several non-hematopoietic tissues, and may be a useful for subclassifying leukemias.
UR - http://www.scopus.com/inward/record.url?scp=0019904717&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019904717&partnerID=8YFLogxK
U2 - 10.1016/0145-2126(82)90002-9
DO - 10.1016/0145-2126(82)90002-9
M3 - Article
C2 - 6958929
AN - SCOPUS:0019904717
SN - 0145-2126
VL - 6
SP - 449
EP - 464
JO - Leukemia Research
JF - Leukemia Research
IS - 4
ER -